Pancreatic Cancer Research

Clinical trialObservationalCompleted

RNA Sequencing of Solid and Cystic Lesions of the Pancreas

Outcome
Finished, no results posted
Phase
Observational
Status
Completed
Study type
Observational
Start
December 2012
Ended
December 2019
Enrollment
72 participants
Sites
2
Primary outcomes
Gene classifier that will classify lesions as benign or malignant with 95% certainty
Sponsor type
Academic / other
Results posted
No
Last update
10 January 2020

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The nature of cysts and solid masses in the pancreas can be difficult to diagnose. They may be benign, precancerous, or cancer. Current tests such as cytology (looking under a microscope) and tumor markers do not always give us the answer. The investigators are looking for genetic markers on biopsy specimens from the pancreas that will give us a better test for diagnosis. This study is only for diagnosing these lesions. The investigators are not treating any patients.